JP2010065046A5 - - Google Patents

Download PDF

Info

Publication number
JP2010065046A5
JP2010065046A5 JP2009251464A JP2009251464A JP2010065046A5 JP 2010065046 A5 JP2010065046 A5 JP 2010065046A5 JP 2009251464 A JP2009251464 A JP 2009251464A JP 2009251464 A JP2009251464 A JP 2009251464A JP 2010065046 A5 JP2010065046 A5 JP 2010065046A5
Authority
JP
Japan
Prior art keywords
seq
peptide
amino acid
sequence
cell epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009251464A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010065046A (ja
JP5345920B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010065046A publication Critical patent/JP2010065046A/ja
Publication of JP2010065046A5 publication Critical patent/JP2010065046A5/ja
Application granted granted Critical
Publication of JP5345920B2 publication Critical patent/JP5345920B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2009251464A 2002-04-19 2009-10-30 アルツハイマー病の処置のための免疫学的方法および組成物 Expired - Fee Related JP5345920B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37391402P 2002-04-19 2002-04-19
US60/373,914 2002-04-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003586180A Division JP4662719B2 (ja) 2002-04-19 2003-04-07 アルツハイマー病の処置のための免疫学的方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012249078A Division JP2013075898A (ja) 2002-04-19 2012-11-13 アルツハイマー病の処置のための免疫学的方法および組成物

Publications (3)

Publication Number Publication Date
JP2010065046A JP2010065046A (ja) 2010-03-25
JP2010065046A5 true JP2010065046A5 (enExample) 2010-11-25
JP5345920B2 JP5345920B2 (ja) 2013-11-20

Family

ID=29251102

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003586180A Expired - Fee Related JP4662719B2 (ja) 2002-04-19 2003-04-07 アルツハイマー病の処置のための免疫学的方法および組成物
JP2009251464A Expired - Fee Related JP5345920B2 (ja) 2002-04-19 2009-10-30 アルツハイマー病の処置のための免疫学的方法および組成物
JP2012249078A Withdrawn JP2013075898A (ja) 2002-04-19 2012-11-13 アルツハイマー病の処置のための免疫学的方法および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003586180A Expired - Fee Related JP4662719B2 (ja) 2002-04-19 2003-04-07 アルツハイマー病の処置のための免疫学的方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012249078A Withdrawn JP2013075898A (ja) 2002-04-19 2012-11-13 アルツハイマー病の処置のための免疫学的方法および組成物

Country Status (17)

Country Link
US (5) US20030232758A1 (enExample)
EP (2) EP1497321B1 (enExample)
JP (3) JP4662719B2 (enExample)
KR (1) KR100994748B1 (enExample)
CN (1) CN100360555C (enExample)
AT (1) ATE514707T1 (enExample)
AU (1) AU2003218560B2 (enExample)
CA (1) CA2481952C (enExample)
ES (1) ES2368907T3 (enExample)
IL (3) IL164643A0 (enExample)
MX (1) MXPA04010255A (enExample)
NO (2) NO335192B1 (enExample)
NZ (1) NZ536064A (enExample)
PL (1) PL209696B1 (enExample)
SG (1) SG173214A1 (enExample)
WO (1) WO2003089460A1 (enExample)
ZA (1) ZA200408811B (enExample)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2082749A3 (en) 2000-07-07 2010-06-30 Bioarctic Neuroscience AB Prevention and treatment of Alzheimer's disease
WO2003039467A2 (en) * 2001-11-02 2003-05-15 Diagenics International Corporation Monoclonal antibodies specific for beta-amyloid.
US20050106626A1 (en) * 2002-10-20 2005-05-19 George Pieczenik Ligand binding of amyloid peptide protein epitope
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
SE0401601D0 (sv) 2004-06-21 2004-06-21 Bioarctic Neuroscience Ab Protofibril specific antibodies and uses thereof
US8193250B2 (en) 2004-10-22 2012-06-05 Mount Sinai School Of Medicine Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system
JP2008519988A (ja) * 2004-11-12 2008-06-12 ファイザー・インク アミロイド−ベータペプチドを測定する方法
PT1976877E (pt) 2005-11-30 2014-04-29 Abbvie Inc Anticorpos monoclonais contra proteína beta-amilóide e suas utilizações
BRPI0619249A2 (pt) 2005-11-30 2011-09-20 Abbott Lab anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
MX2008007477A (es) 2005-12-12 2008-09-03 Ac Immune Sa Anticuerpos monoclonales especificos 1-42 beta con propiedades terapeuticas.
US8034353B2 (en) 2006-02-22 2011-10-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Peptide vaccine for inducing the production of anti-amyloid β-peptide antibody
BRPI0709050B1 (pt) 2006-03-23 2018-12-26 Bioarctic Neuroscience Ab anticorpo ou fragmento do mesmo, composição, métodos para detectar protofibrilas ab in vitro, e, uso do anticorpo
WO2007126111A1 (ja) * 2006-04-28 2007-11-08 Kagoshima University アミロイドβ線維化阻害ペプチド
NZ574188A (en) 2006-07-14 2012-05-25 Ac Immune Sa Humanized antibody against amyloid beta
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2094730A4 (en) * 2006-12-07 2010-08-04 Mayo Foundation METHOD AND MATERIALS ASSOCIATED WITH ANTI-AMYLOID ANTIBODIES
HRP20140049T1 (hr) * 2007-01-05 2014-02-28 University Of Zürich Anti beta-amiloid antitijela i njihova upotreba
EP2124952A2 (en) 2007-02-27 2009-12-02 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
EP2586795B1 (en) 2007-10-05 2018-05-16 Genentech, Inc. Use of anti-amyloid beta antibody in ocular diseases
US8815794B2 (en) * 2008-08-28 2014-08-26 The Research Foundation For The State University Of New York Treatment of amyloidoses using myelin basic protein and fragments thereof
US8912145B2 (en) 2008-11-28 2014-12-16 Hokko Chemical Industry Co., Ltd. Vaccine composition for prophylaxis and/or therapy of Alzheimer's disease
WO2010061899A1 (ja) * 2008-11-28 2010-06-03 北興化学工業株式会社 ワクチンを蓄積する形質転換ダイズ植物およびその利用
CN101797493B (zh) * 2009-02-06 2014-05-21 上海抗体药物国家工程研究中心有限公司 一种在反应釜中制备亲和层析介质的方法
CN101486768B (zh) * 2009-02-25 2012-05-30 吉林大学 一种用于治疗阿尔茨海默氏病的抗原蛋白及蛋白基因
US9256007B2 (en) * 2009-04-21 2016-02-09 Svv Technology Innovations, Inc. Light collection and illumination systems employing planar waveguide
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
EP2558494B1 (en) 2010-04-15 2018-05-23 AbbVie Inc. Amyloid-beta binding proteins
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
AU2011282536B2 (en) 2010-07-30 2015-12-24 Ac Immune S.A. Safe and functional humanized anti beta-amyloid antibody
CN105348387B (zh) 2010-08-14 2020-08-25 Abbvie 公司 β淀粉样蛋白结合蛋白
US20120328605A1 (en) * 2010-10-27 2012-12-27 Daniel Larocque Compositions and uses
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
DE102011057019A1 (de) * 2011-12-23 2013-06-27 Forschungszentrum Jülich GmbH Standard zur Quantifizierung von pathogenen Aggregaten aus körpereigenen Proteinen
JP6130401B2 (ja) * 2012-01-20 2017-05-17 アンナプラガダ，アナンス 医学画像を客観的に特徴付けるための方法および組成物
US9534048B2 (en) * 2012-08-24 2017-01-03 University Health Network Antibodies to TTR and methods of use
EP2895512B1 (en) * 2012-09-12 2018-07-04 Neurimmune Holding AG Human islet amyloid polypeptide (hiapp) specific antibodies and uses thereof
EP2906597B1 (en) * 2012-10-15 2020-04-08 Medimmune Limited Antibodies to amyloid beta
US10195257B2 (en) 2013-07-28 2019-02-05 Qantu Therapeutics, Inc. Vaccine formulations comprising quillaja desacylsaponins and beta amyloid peptides or tau protein to induce a Th2 immune response
CA2946931A1 (en) 2014-04-29 2015-11-05 Affiris Ag Treatment and prevention of alzheimer's disease (ad)
HRP20210680T1 (hr) 2014-07-10 2021-06-11 Bioarctic Ab POBOLJŠANA PROTUTIJELA KOJA VEŽU Aβ PROTOFIBRIL
MA41115A (fr) 2014-12-02 2017-10-10 Biogen Int Neuroscience Gmbh Procédé de traitement de la maladie d'alzheimer
JP7452829B2 (ja) * 2015-11-09 2024-03-19 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア アミロイドベータのエピトープおよびそれに対する抗体
WO2017098516A1 (en) * 2015-12-10 2017-06-15 The National Institute for Biotechnology in the Negev Ltd. VARIANTS OF AMYLOID beta-PROTEIN PRECURSOR INHIBITOR DOMAIN
MY194462A (en) * 2016-11-25 2022-11-30 Genuv Inc Composition for Promoting Differentiation of and Protecting Neural Stem Cells and Method for Inducing Neural Regeneration using same
EP3658172A4 (en) 2017-07-25 2021-05-05 TrueBinding, Inc. TREATING CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND HIS LIGAND
AU2018321335B2 (en) 2017-08-22 2025-08-14 Biogen Ma Inc. Pharmaceutical compositions containing anti-beta amyloid antibodies
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
EA202091012A1 (ru) 2017-10-25 2020-08-27 Янссен Фармасьютикалз, Инк. Композиции фосфорилированных тау-пептидов и их применения
EP3793583A4 (en) * 2018-05-18 2022-03-09 Université Laval USE OF A NOD2 AGONIST FOR THE TREATMENT, PROPHYLAXIS AND/OR DELAYING THE ONSET OF MULTIPLE SCLEROSIS AND ALZHEIMER'S DISEASE
CN113711036B (zh) 2019-01-30 2025-03-18 真和制药有限公司 抗gal3抗体及其用途
CN113710269A (zh) * 2019-02-08 2021-11-26 Ac免疫有限公司 磷酸化Tau肽疫苗的安全施用方法
CN113614101B (zh) * 2019-02-22 2024-07-16 洛约拉马利蒙特大学 淀粉样肽的变体
MA55902A (fr) 2019-04-24 2022-03-16 Ac Immune Sa Administration hétérologue de vaccins tau
KR20220137674A (ko) * 2020-02-05 2022-10-12 스미토모 파마 가부시키가이샤 타우병증 및 인지증 관련 질환의 판정약 및 판정 방법
TW202144387A (zh) * 2020-02-11 2021-12-01 美商聯合生物醫學公司 針對胰島澱粉樣多肽（iapp）的胜肽免疫原及其預防和治療與聚集iapp相關疾病的製劑
CA3183431A1 (en) * 2020-05-15 2021-11-18 Vib Vzw Means and methods for the treatment of pathological aggregation
CN116157151A (zh) 2020-05-26 2023-05-23 真和制药有限公司 通过阻断半乳凝素-3治疗炎性疾病的方法
CN115925987B (zh) * 2022-02-28 2026-05-05 安域生物科技(杭州)有限公司 基于β-淀粉样蛋白修饰的抗原多肽及其应用
CN115786260B (zh) * 2022-12-26 2024-08-20 海南大学 Aβ42-hIAPP共寡聚化物诱导的AD脑类器官病理模型方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4666829A (en) * 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5874299A (en) 1990-08-29 1999-02-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
CA2138997C (en) 1992-06-25 2003-06-03 Jean-Paul Prieels Vaccine composition containing adjuvants
US5766846A (en) * 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US5840294A (en) 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
WO1994025060A1 (en) * 1993-04-27 1994-11-10 Ladd Anna E Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
US5759551A (en) 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5744144A (en) 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
CA2242851A1 (en) 1995-08-17 1997-02-27 The Ontario Cancer Institute Protein fibril assembly assay
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US6750324B1 (en) * 1997-12-02 2004-06-15 Neuralab Limited Humanized and chimeric N-terminal amyloid beta-antibodies
EP1292187B1 (en) 2000-06-20 2006-04-19 The Governing Council Of The University Of Toronto Transgenic animal model of neurodegenerative disorders
US6310810B1 (en) 2000-07-14 2001-10-30 Raj Kumar Jain High-speed sense amplifier
US6906169B2 (en) * 2001-05-25 2005-06-14 United Biomedical, Inc. Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide

Similar Documents

Publication Publication Date Title
JP2006505502A5 (enExample)
JP2013503110A5 (enExample)
AU2018322482B2 (en) Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (RAGE)
JP2014501510A5 (enExample)
JP2010065037A5 (enExample)
JP2012126742A5 (enExample)
JP2010535026A5 (enExample)
JP2012509295A5 (enExample)
JP2013539454A5 (enExample)
NZ593833A (en) Extended recombinant polypeptides and compositions comprising same
JP2010533478A5 (enExample)
JP2019514426A5 (enExample)
JP2013048638A5 (enExample)
JP2008525033A5 (enExample)
JP2008531734A5 (enExample)
JP2007513634A5 (enExample)
JP2007175057A5 (enExample)
JP2009240315A5 (enExample)
JP2016166211A (ja) Ｇａｄｄ４５β標的医薬
JP2010532978A5 (enExample)
JP2015110654A5 (enExample)
RU2011151877A (ru) Пептиды, проникающие в клетку
RU2016146198A (ru) Терапевтические dll4-связывающие белки
JP2012115277A5 (enExample)
JP2010265269A5 (enExample)